Cargando…
The 2021 European Heart Failure Guidelines: The Case for Personalised Therapeutics
Autor principal: | Shanmugam, Nesan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819603/ https://www.ncbi.nlm.nih.gov/pubmed/35154391 http://dx.doi.org/10.15420/ecr.2021.57 |
Ejemplares similares
-
New Trial Evidence on Heart Failure: Highlights from the European Society of Cardiology Congress 2021
por: Ferrannini, Giulia, et al.
Publicado: (2022) -
2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronisation Therapy
por: Dan, Gheorghe-Andrei
Publicado: (2021) -
European Society of Cardiology Highlights: Late-breaking Science MINOCA/ANOCA
por: Ong, Peter, et al.
Publicado: (2022) -
Comment on the ESC Guidelines 2022 for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
por: Cuervo, David Calvo
Publicado: (2023) -
Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study
por: Borer, Jeffrey S., et al.
Publicado: (2012)